The emerging therapy of this peptide represents a exciting advance in the management of diabetes mellitus type 2. Unlike existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide222340.thelateblog.com/42364556/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment